Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice.
Saved in:
| Title: | Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice. |
|---|---|
| Authors: | Yu RZ; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Graham MJ; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Post N; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Riney S; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Zanardi T; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Hall S; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Burkey J; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Shemesh CS; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Prakash TP; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Seth PP; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Swayze EE; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Geary RS; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Wang Y; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Henry S; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA. |
| Source: | Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2016 May 03; Vol. 5, pp. e317. Date of Electronic Publication: 2016 May 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: Electronic Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27138177 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yu+RZ%22">Yu RZ</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Graham+MJ%22">Graham MJ</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Post+N%22">Post N</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Riney+S%22">Riney S</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Zanardi+T%22">Zanardi T</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Hall+S%22">Hall S</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Burkey+J%22">Burkey J</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Shemesh+CS%22">Shemesh CS</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Prakash+TP%22">Prakash TP</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Seth+PP%22">Seth PP</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Swayze+EE%22">Swayze EE</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Geary+RS%22">Geary RS</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Henry+S%22">Henry S</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101581621%22">Molecular therapy. Nucleic acids</searchLink> [Mol Ther Nucleic Acids] 2016 May 03; Vol. 5, pp. e317. <i>Date of Electronic Publication: </i>2016 May 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581621 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2162-2531 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221622531%22">21622531 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Nucleic Acids <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27138177 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/mtna.2016.26 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e317 Titles: – TitleFull: Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yu RZ – PersonEntity: Name: NameFull: Graham MJ – PersonEntity: Name: NameFull: Post N – PersonEntity: Name: NameFull: Riney S – PersonEntity: Name: NameFull: Zanardi T – PersonEntity: Name: NameFull: Hall S – PersonEntity: Name: NameFull: Burkey J – PersonEntity: Name: NameFull: Shemesh CS – PersonEntity: Name: NameFull: Prakash TP – PersonEntity: Name: NameFull: Seth PP – PersonEntity: Name: NameFull: Swayze EE – PersonEntity: Name: NameFull: Geary RS – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Henry S IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 05 Text: 2016 May 03 Type: published Y: 2016 Identifiers: – Type: issn-print Value: 2162-2531 Numbering: – Type: volume Value: 5 Titles: – TitleFull: Molecular therapy. Nucleic acids Type: main |
| ResultId | 1 |